| Similar Articles |
|---|
 |
The Motley Fool
November 1, 2011
Anders Bylund |
Can You Afford to Ignore This Stock? Nam Tai raised its dividends by 40% and sees double the sales in 2012. Do you really want to miss out?   |
The Motley Fool
June 21, 2011
Jim Mueller |
Rising Star Sell: Lightening the Nam Tai Position The Motley Fool Messed-Up Expectations portfolio's position in Nam Tai is too large for the risk, and tomorrow will be selling 50 of the 105 shares it currently owns. |
The Motley Fool
August 1, 2005
Stephen D. Simpson |
Nam Tai's Volume Play Margins aren't what they used to be for this electronics assembler, but business is healthy all the same. Investors, take note. |
The Motley Fool
July 31, 2006
Stephen D. Simpson |
Nam Tai Gets Nailed Perhaps the small Hong Kong-based electronics manufacturer had its current scenario in mind when it decided to cut dividend guidance a little while back. Shares are getting smacked around today, after the company posted uninspiring results and iffy guidance. |
The Motley Fool
February 13, 2006
Stephen D. Simpson |
Win, Lose, or Nam Tai The Chinese electronics assembler is still winning the race between revenue growth and margin deterioration. However, there are a couple of oddities here that investors should pay attention to. |
The Motley Fool
August 2, 2010
Anders Bylund |
Small-Cap Strategy 101: Expansion Now, Dividends Later There's good news out of China this morning: Shares of Shenzhen-based electronics manufacturer Nam Tai Electronics are up 7% thanks to an excellent earnings report. |
The Motley Fool
February 10, 2009
Anders Bylund |
Nam Tai Is Right to Be Cocky Nam Tai will come roaring back in the end, reinstating dividends and regaining investor confidence. Their operating record will once again speak for itself. |
The Motley Fool
May 15, 2006
Stephen D. Simpson |
Nothing Normal With Nam Tai Investors, there are plenty of quirky things with this Chinese electronics assembler, a rare growth-income play. |
The Motley Fool
February 7, 2005
Stephen D. Simpson |
Nam Tai Shares the Wealth The small Hong Kong-based electronics manufacturer shows that growth and dividends are not mutually exclusive. |
The Motley Fool
March 9, 2011
Jim Mueller |
Rising Star Buy: Nam Tai Electronics How messed up are your expectations, Nam Tai Electronics? |
The Motley Fool
June 19, 2009
Eric Bleeker |
Is This China Cheapie a Buy? Its industry may be horrible, but Nam Tai's share price looks mighty tempting. |
The Motley Fool
October 31, 2005
Stephen D. Simpson |
Nam Tai's Error of Margin Margin risk takes a bite out of this quarter's earnings. Though it is presently heavily weighted toward cell phone products, Nam Tai does have a respectable consumer electronics business that could provide future growth. Investors, take note. |
The Motley Fool
June 29, 2010
Eric Bleeker |
3 China Tech Stocks Flush With Cash Vimicro, Actions Semiconductor, and Nam Tai are all trading near their cash balance. Is that reason enough to buy? |
The Motley Fool
May 11, 2009
Anders Bylund |
Nam Tai Says "Thanks, But No Thanks" Deep discounts might work for retailers, but this electronics manufacturer isn't interested. |
The Motley Fool
November 1, 2010
Anders Bylund |
Bad, Decent, Great: What's Next for Nam Tai? This plucky Chinese gadget builder is coming back strong from a couple of lean years. |
The Motley Fool
July 1, 2005
Nathan Parmelee |
Starting Out With Dividends Use dividend-paying stocks as the foundation for your retirement portfolio strategy. |
The Motley Fool
May 3, 2005
Stephen D. Simpson |
Nam Tai Phones It In The Hong Kong electronics company's decision to focus on cell phones is hurting margins, but growth is still on track for now. Investors, take note. |
The Motley Fool
March 30, 2011
Jim Mueller |
Rising Star Buy: Time for Some More Nam Tai Electronics One tsunami and a 13% drop later and it's time to pick up some more of this electronic component manufacturer. |
The Motley Fool
November 12, 2007
Brian Lawler |
Vanda Gets Set for a Busy 2008 Although it has no marketed products, Vanda Pharmaceuticals third-quarter reports set the stage for an exciting 2008. Investors. take note. |
The Motley Fool
April 1, 2011
Jim Mueller |
Messed-Up Expectation Investing Is Working We're five months in and competing against a red-hot stock market. It's still probably too early to judge the success or failure of the Messed-Up Expectations Portfolio's performance, but early signs are encouraging. |
The Motley Fool
December 7, 2006
Billy Fisher |
Breakout at Vanda Good news on the company's schizophrenia drug sends its shares skyrocketing. |
The Motley Fool
July 30, 2007
Anders Bylund |
Nam Tai Nudges High: Fool by Numbers The electronic and component manufacturer released second-quarter 2007 earnings: Income Statement Highlights... Margin Checkup... Balance Sheet Highlights... Cash Flow Highlights... |
The Motley Fool
May 18, 2009
Brian Orelli |
Is There Life After 600% Returns? Just because a drug company gets a massive increase in the stock price after a positive clinical trial or an FDA approval, that doesn't mean all the growth is completely factored into the stock price. |
The Motley Fool
November 9, 2006
Tim Hanson |
5 More Turnaround Stocks It's too bad the election didn't sink the stock market: Kongzhong... Legg Mason... Nam Tai Electronics... Patterston-UTI Energy... U.S. Physical Therapy... |
The Motley Fool
July 1, 2011
Jim Mueller |
7 Companies I'm Invested in Today The end-of-quarter review of my Rising Star public portfolio. |
The Motley Fool
September 27, 2007
Brian Lawler |
A Step in a Winding Road for Vanda Vanda Pharmaceuticals has submitted a new drug application to the FDA for its lead drug, iloperidone, emphasizing a new approach to reduce safety issues. Investors, take note. |
The Motley Fool
December 22, 2009
Brian Orelli |
2009 Biotech Cheers and Jeers Lessons from biotech's 2009 surprises. Will 2010 be just as exciting? Considering that it's biotech, I'd have to say "yes." |
The Motley Fool
March 31, 2010
Toby Shute |
A-Power Defies Analysis Wall Street finds itself bewildered by this cleantech stock. I'm glad I'm not alone. |
The Motley Fool
June 27, 2008
Brian Lawler |
Vanda's Drug Draws a Yawn Shares of Vanda Pharmaceuticals have fallen more than 20% recently, even though the company said that its phase 3 clinical trial met its primary goal. |
The Motley Fool
December 3, 2010
Toby Shute |
A-Power Gets A-nnihilated The Chinese alt-energy player comes up way short in its latest quarterly report. |
The Motley Fool
July 17, 2006
Stephen D. Simpson |
Nam Tai Saving Its Pennies For this small Hong Kong-based electronics manufacturer, cutting the dividend may not be popular, but it's probably smart. American companies too often hang on to dividend payments that are no longer reflective of the company's real earnings and/or capital needs. |
The Motley Fool
March 27, 2006
Tim Beyers |
Kick Your Stocks Up a Notch When looking for dividend-payers, don't simply screen out debt. A little well-managed debt can help a company earn great returns. |
The Motley Fool
August 27, 2010
Toby Shute |
Will A-Power Investors Ever Catch a Break? The budding wind-turbine manufacturer disappoints, again. |
InternetNews
April 30, 2007
Paul Shread |
Stocks Slump on Slowdown Fears Stocks traded lower Monday on fears that the economy may be cooling too fast, while chip stocks fell anew on pricing concerns... Verizon edged higher on better than expected results... Nam Tai fell on its results... etc. |
The Motley Fool
June 17, 2009
Toby Shute |
A-Power Results Not So A-mazing Earnings miss is a dash of cold water on this hot alternative energy stock. |
